Clinical Trial Update: Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

View source ↗

Summary

Clinical trial update on long-term treatment strategies and effectiveness of secukinumab in Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis within…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enthesitis-related Arthritis
• Juvenile Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Enthesitis-related Arthritis (ERA), Juvenile Psoriatic Arthritis (JPsA) | Status: NOT_YET_RECRUITING